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Specificity engineering is challenging and particularly difficult for enzymes that have the catalytic machinery and
specificity determinants in close proximity. Restriction endonucleases have been used as a paradigm for protein
engineering, but successful cases are rare. Here, we present the results of a directed evolution approach to the
engineering of a dimeric, blunt end cutting restriction enzyme NlaIV (GGN/NCC). Based on the remote similarity
to EcoRV endonuclease, regions for random mutagenesis and in vitro evolution were chosen. The obtained
variants cleaved target sites with an up to 100-fold kcat/KM preference for AT or TA (GGW/WCC) over GC or CG
(GGS/SCC) in the central dinucleotide step, compared to the only ~17-fold preference of the wild-type enzyme.
To understand the basis of the increased specificity, we determined the crystal structure of NlaIV. Despite the
presence of DNA in the crystallization mix, the enzyme crystallized in the free form. We therefore constructed a
computational model of the NlaIV–DNA complex. According to the model, the mutagenesis of the regions that
were in the proximity of DNA did not lead to the desired specificity change, which was instead conveyed in an
indirect manner by substitutions in the more distant regions.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Specificity engineering is a challenging task. Type II
restriction endonucleases provide a good testing
ground for methods to design or evolve specificities.
The altered cleavage preferences can not only be
easily assayed but also be exploited with selection
schemes that use the activity to enrich or deplete DNA
templates for enzymes that have desirable properties
[1]. Despite the advantages of restriction endonucle-
ases in such tasks, successes of rational or semi-
rational specificity engineering are rare [1–5]. This
results in part from the close spatial proximity of
catalytic sites and specificity determining regions,
which makes enzyme activity vulnerable to changes
intended to alter specificity, and in part from manythor(s). Published by Elsevier Ltd. This is
/licenses/by-nc-nd/4.0/).interdependent degrees of freedom of the substrate
DNA, which make detailed modeling difficult.
The restriction endonuclease NlaIV from Neisseria
lactamica is a dimeric enzyme that belongs to the PD-
(D/E)XK class of endonucleases. The only structural
information on NlaIV currently available is based on
computational modeling [6]. Because of the low amino
acid similarity between the enzymeand templates, the
model is of relatively low resolution. Nevertheless,
some of its key features, such as the predicted active
site and some DNA binding residues have already
been validated by site-directed mutagenesis [6].
The enzyme cleaves DNA within the GGN/NCC
sites to blunt-ended products [7]. The central dinucle-
otide step of the target sequence provides an
opportunity to engineer additional specificity. Asan open access article under the CC BY-NC-ND license
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Table 1. Cleavage kinetics of the selected variants
Variant Sequence kcat
(min−1)
AT/GC
ratio
Km
(nM)
AT/GC
ratio
kcat/Km
(s−1 M−1)
AT/GC
ratio
Wild type GGATCC 0.331 (±0.038) 2.88 6.4 (±0.5) 0.17 8.69 × 106 17.01
GGGCCC 0.115 (±0.008) 37.5 (±1.3) 5.11 × 105
I36P/K38R GGATCC 3.890 (±0.270) 231.55 40.2 (±5.0) 2.38 1.61 × 107 97.58
GGGCCC 0.017 (±0.001) 16.9 (±2.6) 1.65 × 105
N178A/K180R GGATCC 0.152 (±0.013) 25.46 22.5 (±2.0) 0.20 1.13 × 106 126.40
GGGCCC 0.006 (±0.000) 111.2 (±15.2) 8.94 × 103
S176A/K179A/K180W GGATCC 1.010 (±0.090) 27.60 19.4 (±1.0) 0.69 8.68 × 106 40.19
GGGCCC 0.037 (±0.002) 28.3 (±2.5) 2.16 × 105
Error values are standard deviations from triplicate experiments.
Table 2. Regions selected for mutagenesis
Region Residues selected for mutagenesis (substitution
frequency)
A I36 (1.0), K38 (0.5), K40 (0.5)
B K38 (1.0), K40 (0.3), D41 (1.0), G44 (0.3), N45 (0.3)
C D41 (1.0), G44 (0.5), N45 (0.5)
D T68 (1.0), Q69 (1.0)
E S176 (0.8), N178 (0.8), K179 (0.8), K180 (0.8)
Desired substitution frequencies are given in brackets.
2083Specificity of NlaIV Restriction EndonucleaseNlaIV is dimeric, it recognizes only “half” of its target
independently and the interactions with the other half
are enforced by the 2-fold symmetry of the enzyme-
DNA complex [6]. Therefore, the specificity can only
be evolved or engineered for one of the two central
positions in the target sequence, and the selectivity for
other position is symmetry imposed. Hence, only four
non-degenerate specializations of the 5′-NN-3′ dinu-
cleotide step are possible, namely AT, TA, GC and
CG. If binary ambiguities are allowed, the YR, RY, SS
and WW steps become possible, where Y stands for
pyrimidine, R for purine, S (“strong”) for G or C and W
(“weak”) for A or T. In principle, there is also the
possibility of triply degenerate specificity (e.g., H for A,
C or T), but recognition of all but one base in any given
position is difficult to implement mechanistically and
rarely found in natural restriction enzymes. Hence,
this possibility will not be discussed further.
Here, we present an adaptation of the compartmen-
talization strategy for in vitro protein evolution [8–10] to
specificity engineering of restriction endonucleases.
Using NlaIV as an example, we performed a selection
strategy that enhanced the natural preference of the
enzyme for anATover aGCstep. Although thepositive
selectionwas applied only for cleavage of AT steps, the
evolved enzymes also cleave targets with central TA
steps. Thus, the engineering created a new endonu-
clease with specificity for palindromic GGW/WCC
target sequences, which is novel and not known to
occur for any naturally evolved enzyme. We also
present a crystal structure of NlaIV that demonstrates
that the changesmade to alter its specificity are likely to
be positioned away from the target DNA, act indirectly
and not by specific interactions with the DNA bases.
Results
Expression and characterization of NlaIV
As a starting point for the in vitro evolution of NlaIV
specificity, we tested whether the enzyme had an
intrinsic preference for the central dinucleotide step. A
detailed kinetic characterization revealed that the kcat/KM value, a measure of the enzyme efficiency, was
about 17-fold higher for the GGATCC than for the
GGGCCC target sequence (Table 1). The higher kcat/
KM value was a result of approximately 6-fold tighter
binding and a 3-fold faster catalytic rate. The finding
suggested that it may be possible to build on this
preference and evolve NlaIV variants with genuine
GGATCC specificity.
Design of the library of NlaIV variants
Sites for mutagenesis were chosen based on the
published model of the NlaIV in complex with target
DNA [6]. Altogether, five partially overlapping regions
(here labeled from A to E) were selected, and in each
region, the codons for 2–5 amino acids were altered
(Table 2 and Supplementary Fig. S1). For many
codons, only the distinction between a pyrimidine
and a purine base in the third position is relevant for the
coding capacity. Therefore, triplet randomization with
NNS instead of NNN reduces the complexity of the
library at the nucleic acid level 2-fold, without altering
the range of amino acids that can be encoded and
decreasing stop codon frequency from 3/64 (0.047) to
1/32 (0.031). Such reduction of the genetic code
results also in more even distribution of codons for all
amino acids. For instance, the relative frequency of
methionine and tryptophan codons increases from
0.016 (1/64) to 0.031 (1/32). To increase the likelihood
of substitutions in promising sites at the expense of
substitutions in less promising sites, the extent of the
2084 Specificity of NlaIV Restriction Endonucleasemutation ratewas separately chosen for each position,
according to an estimate of the probability that it will
contribute to specificity (Table 2). By a “split and mix”
strategy, the codon triplet for the wild-type amino acid
was mixed with the NNS codon in a predefined,
position-specific ratio. Sequencing of the two of the
libraries confirmed that this procedure generated
approximately the expected ratios of original and
altered codons (Supplementary Table S1).
Selection system for the NlaIV activity
For in vitro evolution of NlaIV toward variants of
altered specificity, we adopted the strategy of directed
evolution by compartmentalization [8–10]. The DNA
for wild-type or mutated NlaIV was embedded in
droplets of a water in oil emulsion system, ideally in
such a manner that there was only a single molecule
of DNA with the coding frame in each droplet. The
templatewas transcribed and translated in the droplet,
and acted on itself. We embedded the NlaIV coding
sequence with T7 promoter in between two restriction
sites, a GGSSCCand aGGATCC site. TheGGSSCC
site was preceded by an upstream primer sequence,
and the GGATCC was followed by a downstream
primer binding site. The biotinylation at the 5′ end
of the non-coding strand was introduced using a
biotinylated reverse primer in the PCR run. After
transcription and translation in droplets, the emulsion
was broken and the DNA attached to biotin was
removed by pull-down using streptavidin beads. This
step ensured that only the open reading frames
coding for NlaIV variants able to cleave the GGATCC
sequence, and sever the open reading frame from the
biotin tag, were retained (Fig. 1 and Supplementary
Fig. S2).
Subsequently, a two-step PCR reaction of the
template mixture was carried out, that reintroduced
the complete cleavage sites and the biotin tag. The
upstream PCR primer for the first reaction was
designed in such a way that only the NlaIV open
reading frames that were not severed by cleavage of
the GGSSCC site could be amplified. Protein expres-
sion in the droplets, biotin pull-down and PCR were
reiterated five times. Note that in any given drop, only
oneof thepossibleSSsequences, that is,GG,GC,CG
or CC, is present. However, when the procedure isFig. 1. Selection strategy of NlaIVreiterated, a new implementation of the SS consensus
is chosen in each round. Therefore, eventually all four
variants of the SS sequence were potentially selected
against. The selection was carried out independently
for the five A-E pools, each representing a set of NlaIV
variants with mutagenesis sites concentrated in a
particular region of the protein (Fig. 1 and Supplemen-
tary Fig. S2).
The selected NlaIV variants were initially screened
against phage λ DNA. Variants that generated
cleavage patterns distinct from the wild-type enzyme
were further characterized on a panel of short DNA
substrates containing a single GGNNCC recognition
site.Without the requirement of palindromic symmetry,
there are 16 possibilities for the central 5′-NN-3′ step.
Four of them, AT, TA, GC andCG, are compatible with
2-fold symmetry. Each of the other 12 dinucleotide
steps has a non-identical reverse complement. There-
fore, of the remaining 12 steps, only 6 have to be
tested, which brings the number of targets to a total of
4 + 6 = 10 (Fig. 2).
Among the five pools of NlaIV variants, pools A
(potential alterations of I36, K38, K40), D (T68, Q69)
and E (S176, N178, K179, K180) proved successful.
From the transformation of DNA representing these
pools, single colonies that exhibited altered NlaIV
activity could be isolated. These were I36P/K38R,
I36R/K40R, W68T/V69Q, S176A/K179A/K180W,
N178A/K180R and S176R/N178V/K179A/K180A.
We also constructed a variant with two altered
regions combined (I36P/K38R/N178A/K180R). Of
note, at least two mutations were required to alter
specificity. Interestingly, all variants not only showed
specificity against the central SS steps and for the AT
step, as expected based on the selection strategy, but
also continued to cleave targets with the TA step at the
center. This could indicate either that the positive
selection for the GGATCC specificity was not very
effective, which would lead to GGWWCC preference
by anti-selection against GGSSCC, or that the
mechanistic constraints of the AT step recognition
could automatically favor the TA step as well.
Although NlaIV is dimeric, one variant of the enzyme
from the E-pool, N178A/K180R, also cleaved DNA
with the non-palindromic target sequence GGTGCC.
Cleavage of “slightly” non-palindromic DNA by a
dimeric restriction endonuclease is not hard to explainvariants with altered specificity.
Fig. 2. Initial screening of the selected NlaIV variants.
NlaIV variants were screened on a panel of ten 444-bp-long
substrates with all dinucleotide combinations in the center of
NlaIV target site.The substrate (0.1 μg) was digested with
0.5 µl of enzyme variants (equivalent of 180 μl of the induced
culture, on average 50 ng of the enzyme) for 1 h. DNA size
standard, pUC19 DNA digested with MspI; S, substrate; P,
product.
2085Specificity of NlaIV Restriction Endonucleasefor one strand. However, since an asymmetric binding
mode has to result from the violation of the 2-fold
symmetry in the target, it is surprising that both DNA
strands are cleaved. For now, we lack a clear
explanation for the mechanistic basis of this observa-
tion. Double-strand cleavage of symmetry breaking,
asymmetric oligoduplexes by dimeric restriction endo-
nucleases otherwise imposing 2-fold symmetry has
not been reported to our knowledge for naturallyFig. 3. Kinetic characterization of themost promising NlaIV var
of the wild-type enzyme.occurring enzymes. However, it is possible that such
activity has been overlooked because of an expected
specificity for palindromic targets.
Kinetic studies of selected NlaIV variants
Four NlaIV variants exhibited the clearest change
of substrate preference with respect to the wild-type
enzyme (I36P/K38R, S176A/K179A/K180W,
N178A/K180R, S176R/N178V/K179A/K180A).
They were therefore further characterized by mea-
suring cleavage rates of two fluorescent substrates
with GGATCC and GGGCCC NlaIV target sites at
50 nM concentrations (Supplementary Figs. S3 and
S4). Interestingly, the combination of changes in two
regions in one NlaIV variant (I36P/K38R/N178A/
K180R) did not cause further improvement of the
enzyme specificity (Fig. 2 and Supplementary Fig.
S4). We determined kcat and KM values for three of
the variants with the most promising properties
(Table 1). The kinetic parameters indicated that
engineering had a moderately detrimental effect on
the binding of DNA with the GGATCC sequence
(Fig. 3). The KM value for DNA with the anti-selected
GGGCCC sequence, already lower in the wild-type
enzyme, deteriorated only for one of the variants
(N178A/K180R), whereas it improved for the other
two. The enhanced preference of the variants for
GGATCC over GGGCCC was therefore predomi-
nantly a kcat effect. Altogether, the 17-fold preference
of the wild-type NlaIV for GGATCC over GGGCCC
was moderately improved to between ~40- and
~130-fold. This increase in specificity did not always
come at the cost of a reduced kcat/KM value for the
desired GGATCC target. In at least one instance of
the I36P/K38R variant, the kcat/KM was improved
nearly 2-fold, whereas it stayed similar to the value
for the wild-type enzyme for the S176A/K179A/
K180W variant and was 10-fold reduced for the
N178A/K180R variant.
Crystal structure of NlaIV
To understand the structural basis of altered
specificity of NlaIV variants, we aimed to solve theiants. The valueswere normalized relatively to the parameters
2086 Specificity of NlaIV Restriction Endonucleasestructure of NlaIV in complex with target DNA. We set
up crystallization trials with NlaIV wild-type (except for
the N-terminal GSH tag—the artifact of the thrombin
catalyzed His6 tag removal) and DNA oligoduplex
containing the GGTACC target sequence. Crystals
grew in the P6(2)22 space group and diffracted to
2.8 Å resolution on a synchrotron beamline. The
structure was experimentally phased using a Ta6Br12
2+
derivative. Despite the presence of DNA in the
crystallization mix, the electron density was present
only for a single NlaIV protomer in the asymmetric unit
but not for the DNA. The solvent content of the crystals
equals almost 60%. The packing of themolecules is so
loose that the presence of disordered DNA molecules
cannot be excluded, but clearly, no substrate is
specifically bound to the enzyme (Supplementary
Fig. S5).
A comparison with other structures in the PDB
performed with the DALI server [11] confirmed that
NlaIV was structurally most similar to EcoRV (Z-
score of 8.7). Other blunt-end cutting enzymes were
only slightly more distant (Z-scores of 7.9 for HincII
and SwaI). Overall, the crystal structure agreed with
the previously published computational model of
NlaIV [12]. However, shifts in the register in
peripheral regions and substantial differences in
the interface region were observed.
Dimerization region
The NlaIV protomers in the crystal are positioned
close to the 2-fold axis. Application of the crystallo-
graphic symmetry completes the NlaIV dimer (Fig.
4). According to the PISA server [13,14], the
dimerization interface extends over 1315 Å2 and
has a Δ iG ~ −20 kcal/mol (predicted solvation free
energy gain upon dimer formation). According to the
calculation, the probability of a chance occurrence of
the contact is below 2%, confirming that the
crystallographic interface is likely to be relevant
also in solution.Fig. 4. Overall structure of the crystallographically observed
the help of crystallographic 2-fold axis. The location of the axisThe dimerization interface of the NlaIV shares some
similarities with the one of EcoRV. It is composed of β-
strands comprising residues 27–29 of the two proto-
mers, that together with two other strands (residues
34–36) form a four-stranded anti-parallel β-sheet
connected via main chain hydrogen bonds. The
interface is completed by the downstream α-helices
of the two protomers (residues 41–57). The analogous
elements form the interface of EcoRV (four β-strands
and two α-helices comprising residues 20–25, 30–32
and 37–58, respectively) (Supplementary Fig. S6).
The additional structural fragment that contributes to
the interface is locatedmuch further downstream in the
sequence and is much more elaborate in EcoRV than
in NlaIV (residues 135–137 in NlaIV and 143–156 in
EcoRV).
The angle between the NlaIV protomers in the dimer
present in the crystal is remarkably different from the
one of theEcoRV–DNAcomplex [15]. TheNlaIV dimer
is wide-open, with active sites spaced too far apart for
concerted cleavage of a DNA duplex. Therefore, we
expect that the interface has to change upon DNA
binding: presumably by a slight deformation of the β-
sheet into a more barrel-like structure that would bring
the active sites into closer proximity.
NlaIV active site
NlaIV has an active site typical for a PD-(D/E)XK
restriction endonuclease, anchored in the context of
the canonical α-β1-β2-β3motif. As expected, there is
a PD motif at the beginning of strand β1, where D73
plays the role of the “PD” aspartate. Downstream,
there is the usual (D/E)XK motif, consisting in NlaIV
of E87 and K89, the putative activator residue for the
hydrolytic water molecule. The assignment of these
residues is consistent with the earlier structure
prediction. In PD-(D/E)XK restriction endonucle-
ases, an acidic residue is expected in the α-helix
immediately upstream of the α-β1-β2-β3 motif. This
residue is E45 in the case of EcoRV, but somewhatNlaIV dimer. The protein dimer has been generated with
is marked in the two orientations with an arrow and an oval.
2087Specificity of NlaIV Restriction Endonucleaseatypically a glutamine, Q48, and not an acidic
residue in NlaIV. The active-site residue in the α-
helix typically coordinates water molecules that
serve as ligands to one or two metal ions in the
active site of a PD-(D/E)XK restriction endonucle-
ases [15,16]. For this role, a glutamine is equally
suitable as the more typically present glutamate.
Alternatively, this residue might be unnecessary for
the catalytic function of the NlaIV endonuclease, as
observed for someother enzymes [17,18]. Sincemetal
ions are not seen in the NlaIV active site, presumably
because of the absence of the substrate DNA, this
question remains open (Fig. 5).
Recognition of the central base pairs
Structure comparisons performed with the help of
the DALI server [11] confirm the conclusion previously
reached based on the amino acid sequence alone [6]
that among the restriction endonucleases of known
structure, NlaIV (GGN/NCC) ismost similar to the blunt
end cutter EcoRV (GAT/ATC). Thus, onemay assume
that DNA could adopt a very similar conformation in
the NlaIV- and EcoRV-specific complexes. However,
this conclusion cannot be fully correct. In EcoRV, the
central dinucleotide step is not in direct contact with
any amino acid residues, and instead, the 5′-TA-3′
specificity is largely enforced by theDNA conformation
alone. Modeling shows that the replacement of
the TA by an RY step that has identical 2′-deoxyribose
positions and glycosidic bond angles leads to clashes
of the 6-amino or 6-keto groups of the purine bases.
Moreover, substantial clashes are also expected for
the exocyclic methyl group of thymine in the 5′-AT-3′
sequence context. The structural studies of
the complexes of EcoRV endonuclease with non-
cognate DNA with the 5′-AT-3′ dinucleotide in
the center indicate that the alleviation of the steric
conflicts leads to the destabilization of the active site
and a 104-fold difference in the cleavage efficiencyFig. 5. Comparison of the NlaIV, Eco[21]. In contrast, the substitution of the TA step with the
CI (or 5mCI) step results in an almost unperturbed
conformation of the EcoRV–DNA complex [22]. Thus,
the EcoRV complex-derived DNA conformation in the
caseofNlaIV should not be compatible at least with the
GGRYCC subset of the GGNNCC NlaIV target
sequences (Supplementary Fig. S7).
Recognition of the outer base pairs
The recognition of the outer base pairs of the
target sequence is not likely to be conserved
between EcoRV and NlaIV and is thus difficult to
predict. The only residue that is conservatively
substituted according to the structure-based se-
quence alignment and might fulfill the same role is
Q69 in NlaIV that corresponds to N70 in EcoRV. This
residue donates a hydrogen bond to the O2 group of
the thymine in the non-central A:T pair of the GAT/
ATC target sequence of EcoRV. NlaIV recognizes a
G:C pair in this position (GGN/NCC), and thus, the
same hydrogen bond can also be formed. The other
hydrogen bonds responsible for the recognition of
the target base pairs are provided by the side chain
and main chain atoms of the 182–188 fragment of
EcoRV. This fragment is conserved neither in
length nor in sequence in NlaIV, and thus, the
specificity providing residues cannot be directly
deduced from the structure-based sequence align-
ment. Based on the proximity to the target DNA, one
can only suspect that the fragments of the enzyme
that are responsible for base and backbone
contacts with the DNA are located in three regions
of the protein, namely, residues 68–69, 100–105
and 160–170. One of these regions (T68-Q69) was
included in the mutagenesis, but did not yield
variants with altered specificity, most likely due to
the contacts with the other bases of the target
sequence that needed to be preserved (Supple-
mentary Figs. S8 and S9).RV [19] and HincII [20] active sites.
2088 Specificity of NlaIV Restriction EndonucleaseMapping of mutagenized regions onto the NlaIV–
DNA complex model
The sites of random mutagenesis were selected
based on a model of the NlaIV–DNA complex
generated before the structure of the apo form of
the enzyme was determined [6]. The model was
obtained with the help of the EcoRV–DNA structure
[15] that was the best template at the time.
Surprisingly, the amino acid exchanges in regions
that were correctly predicted to be located in the
immediate vicinity of the substrate DNA did not result
in the desired specificity change. The best results
were instead obtained by substitutions that proved to
be located in the parts of the protein that do not
directly contact the substrate (at least for the DNA
length present in the EcoRV crystal and thus also in
the NlaIV model). The sites of substitutions that led
to the most prominent specificity alterations are
instead positioned either on the dimerization inter-
face between the two protomers (residues 36 and
38) or in the region close to the exit tunnel of the DNA
(residues 176–180). If the current model for the
NlaIV complex with DNA is correct, the observed
specificity change must be attributed to indirect
effects of the introduced substitutions on the NlaIV–
DNA interaction in the course of catalysis, which is
reflected in the dominant role of the kcat contribution
(Fig. 6, and Supplementary Figs. S8 and S10).
Discussion
Building on natural specificity preferences
The recognition sequence of NlaIV has been
described as GGN/NCC, but the naturally occurring
enzyme nevertheless exhibits a 17-fold preference
(judging from kcat/KM) for the AT step over the GCstep in the center. The directed evolution approach
to achieve GGA/TCC specificity could therefore build
on pre-existing preference. Surprisingly, the evolu-
tion of GGA/TCC specificity also increased the
activity of NlaIV toward GGT/ACC. This could
indicate that anti-selection against enzyme variants
cleaving a target sequence with the SS step at the
center was more efficient than positive selection for
enzymes with activity toward the GGA/TCC sub-
strate. Formally, anti-selection against specificity for
a 5′-SS-3′ step at the center should result in a
preference for 5′-WW-3′. For NlaIV, this indeed
appeared to occur and the selectivity for palindromic
GGW/WCC target sequences was obtained.
Specificity changes are mostly kcat, not KM effects
It was initially surprising to us that the changes in
specificity were primarily caused by differences in
kcat values. The result need not indicate that specificity
alterations are more easily achieved by kcat than by KM
changes, but could be the consequence of the specific
selection conditions in our experiment. Reaction rates
depend on the kcat/KM ratio in the regime where the
substrate is much more abundant than the enzyme,
and concentrations are low compared to KM, so that
changes in the latter control the concentration of
productive complexes in solution. In the emulsion
droplets, at least in theory there should only be a single
DNA template (with two potential target sites), which
can beused to generatemultiplemRNA transcripts and
many protein copies. Although we have not directly
measured this, it is likely that the emulsion experiments
are carried out in the regime of enzyme excess over
substrate, and possibly also in conditions where the
enzyme concentration may exceed the low (tight) KM
for the formation of specific restriction endonuclease
DNA complexes. At least in the latter regime, reaction
rates are only dependent on kcat, and it therefore shouldFig. 6. Localization of the muta-
genesis regions in the NlaIV–DNA
model. The residues that have been
randomly mutagenized are indicat-
ed as spheres: (a) the sites that
when mutated led to the specificity
change and (b) the sites that led to
at most minor effects.
2089Specificity of NlaIV Restriction Endonucleasenot come as a surprise that selection operates on the
kcat and not on KM values.
Comparison of the structural basis of specificity
for the central dinucleotide in blunt end cutters
In this work, we have added additional specificity
to NlaIV, for the central two base pairs. Within the
GGN/NCC context, the engineered preference is
novel, but there are of course naturally occurring
blunt-end cutting restriction endonucleases with spec-
ificity for the two base pairs. REBASE [23] lists
altogether 224 such enzymes. Among these, 114
have a GC, 58 CG, 37 TA, 12 and AT step. There are
also three examples (HinJCI, HincII and HindII) for the
YR step, but no examples for a RY, WW, SS or any
other degenerate dinucleotide steps.
The crystal structures of dimeric PD-(D/E)XK re-
striction enzymes in complex with substrate DNA are
available for all but the AT step. For the TA step, the
examples are EcoRV (GAT/ATC) [15] and SwaI
(ATTT/AAAT) [12], both known for complex modes of
recognition of the central step. For the CG step, NaeIFig. 7. Comparison of the central base pair recognition in th
complexes. Enzymes specific for (a) pyrimidine/purine and (b
orientations. The left panels indicate the residues surrounding
one of them (for all enzymes but DpnI, the recognition of the
bound analogously). A 4 Å distance cutoff was used to locate(GCC/GGC) is so far the only example [24]. For theGC
step, the examples include PvuII (CAG/CTG) [25] and
ThaI (CG/CG) [16]. Both enzymes recognize the
central step in a fairly canonical manner by a
combination of shape selection and sequence-
specific hydrogen bonding. The AT step is the only
one without clearly documented endonuclease–DNA
complex. DpnI (G6mA/TC) has a 6mAT step at the
center of its target sequence, but the enzyme is
monomeric and cleaves only methylated DNA [26].
There are four palindromic dinucleotide steps
involving 2-fold degenerate base recognition, RY,
YR, WW and SS. HincII [27] is an example enzyme
that exhibits semi-degenerate specificity for the central
step. The DNA in the HincII-DNA complex is strongly
kinked, with major base pair roll and purine cross-
stacking at the center. This DNA conformation
excludes purines in the first position and thus selects
for the YR step. The DNA conformations in the EcoRV
[15] and NaeI [24] complexes are similar, and indeed,
the central base pair steps of their target sequences
are compatible with the YR consensus. However, both
enzymes select among the structurally “allowed”e available blunt end cutting restriction endonuclease DNA
) purine/pyrimidine step in the center are presented in two
both central base pairs, and the right panels indicate only
target site is symmetric, and thus, the second base pair is
the residues surrounding the central base pairs.
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purely by indirect readout. NaeI also uses hydrogen
bonds (involving D146 and K148 residues). PvuII [28]
and ThaI [16] that bind kinked DNA without the roll at
the center have targets with the central GC, which is
not compatible with the YR consensus. Together, the
data make a strong case that DNA structure can help
to select a YR dinucleotide step (Fig. 7).
Selection forWWor SS steps has not yet been seen
for blunt end-cutting enzymes. However, the structural
basis for W or S recognition in the context of pseudo-
palindromic sequences is very well understood. The
distinction can be realized via probing of the base
pairing strength by nucleotide flipping, as exemplified
by the PspGI endonuclease [29,30]. Alternatively, the
enzymes can distinguish W and S pairs by hydrogen
bonds and/or shape selection. Inspection of hydrogen
bonding requirements shows that they are base pair
specific on themajor groove side, and thus, this side is
largely unsuitable for degenerate recognition [31]. In
contrast in the center of the minor groove, the 2-amino
group of guanine is almost in the same position for the
G:CandC:Gpairs andabsent forA:T andT:Apairs. By
testing for the presence or absence of the 2-amino
group, enzymes can distinguish W from S, as
observed for BcnI, MvaI or Hpy99I endonucleases
[32–34].
The structural and biochemical data presented in
this work suggest that the engineered NlaIV variants
do not use probing of the central minor groove position
or nucleotide flipping to achieve the semi-degenerate
WW specificity. Mutations in the dimer interface region
could affect steric crowding in the vicinity of the DNA in
such a manner that 2-amino groups in the central
minor groove position would be better rejected than for
the wild-type NlaIV. However, since the specificity
changes in NlaIV are primarily determined by the kcat
and not KM value, such interpretation of the experi-
mental data cannot be fully correct. Moreover, we do
not see any residues coming closer than 4 Å to the
central minor groove neither in the EcoRV–DNA
structure [19] nor in our NlaIV–DNA complex model.
Therefore, the preference of the engineered NlaIV
variants likely results from the indirect influence of
the DNA sequence on the active site conformation
as implied before for the non-cognate target se-
quences of EcoRV [22] and in line with the dominant
kcat contribution.Materials and Methods
Library construction
The NlaIV REase (NlaIV.R) expression cassette
containing all necessary elements for in vitro transcrip-
tion/translation/selection was constructed using
pNlaRET28 plasmid (Fig. 1 and SupplementaryFig. S1) [6]. Three unique restriction sites (SalI,
EcoRI and Eco52I) were introduced as silent muta-
tions upstream of the intended mutagenesis regions.
Moreover, the NlaIV site 77 bp after NlaIV.R stop
codon was removed so that the whole sequence did
not contain any NlaIV recognition sites (for primers,
see Supplementary Table S2). Mutagenic primers
were generated with ASM-800 DNA synthesizer
(Biosset Ltd.) using split and mix strategy [35,36].
Each synthesis was initiated in all eight columns. At
every split and mix step, the columns were opened,
solid support resin was mixed in an Eppendorf tube
and new columns were filled with mixed resin in the
proportions dictated by the primer design (assuming
90% resin recovery at each mixing step). Synthesis
products were purified on a Glen-Pak™ DNA Purifi-
cation Cartridge (Glen Research), and their purity and
integrity were assayed in denaturing polyacrylamide
gel electrophoresis. Other primers were purchased
from commercial suppliers (Sigma).
Libraries of mutagenized expression cassettes were
generated in two-step PCR reactions (Supplementary
Fig. S1). In the first step, two amplification reactions
were performed. A non-mutagenic reaction amplified
the cassette from the 5′ end up to a unique restriction
site preceding mutagenic region. A second reaction
using a 5′ mutagenic primer then amplified the
expression cassette from the unique restriction site to
the 3′ end of the cassette. Both reaction products were
cleaved at the same site and ligated. The ligation
product of the desired size (containing joined
parts generated in the first step) was gel-purified and
used as a template at the second amplification step. In
this step, the GGSSCC and GGATCC flanking
sequences were added for positive and negative
selection. They were introduced using a non-
biotinylated primer with the GGSSCC NlaIV recogni-
tion sequence and a 5′-biotinylated primer with the
GGATCC sequence.
A variant with two altered regions combined (I36P/
K38R/N178A/K180R) was constructed by replacing
the Eco52I–XhoI segment of the I36P/K38R expres-
sion construct with the corresponding segment of the
N178A/K180R coding sequence.
Invitrocompartmentalization/transcription/transla-
tion and selection of specificity variants
Fiftymicroliters of the in vitro transcription/translation
reaction mix (Rapid Translation System RTS 100,
Escherichia coli HY Kit, Roche) containing 1.7 fmol of
the expression cassette (1.18 ng) and supplemented
with 5 mM MgCl2 were emulsified in 0.95 ml of the
oil/surfactants mix as described [37]. After 6 h of
incubation at 30 °C, the samples were transferred to
37 °C for 3 h, the emulsion was broken by centrifuga-
tion and chloroform extraction, and DNA was precip-
itated from the aqueous phase. Precipitated DNA was
dissolved and mixed with 10 μl of streptavidin
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5 min at room temperature. After separation of the
beads on a magnetic stand, the supernatant was
collected and used for the re-amplification of selected
clones. Two consecutive PCR reactions were used. In
the first reaction, a primer selective for an intact 5′ end
(with the uncleaved GGSSCC NlaIV sequence) was
used in combination with the 3′ primer recreating the
original 3′ end of the expression cassette (with the
GGATCC NlaIV site). In the second PCR reaction, a
primer randomizing the NlaIV site at the 5′ end to
GGSSCC and a 3′ end primer with biotin on the 5′ end
were used to recreate the expression cassette for use
in another in vitro compartmentalization/selection
round. This process was iterated five times, and
aliquots of the selected variants (products of the first
PCR reaction after streptavidin capture)were collected
from each cycle (Supplementary Fig. S2).
Selected variants were cloned as NcoI–XhoI frag-
ments into pET28a vector (Novagene) and trans-
formed into the E. coli strain ER2566 (New England
Biolabs) containing the pM.NlaIVAC plasmid express-
ing the NlaIV methyltransferase. Transformants were
selected on LB with kanamycin, chloramphenicol and
1% glucose and used for expression of the NlaIV
endonuclease. The expression was induced at mid-
logarithmic phase of a culture with 1 mM IPTG, and
cells were harvested 5 h later. Pellets from 15 ml
expression cultures were used to purify His-tagged
NlaIV endonuclease on 20 μl of HIS-Select Nickel
Affinity resin (Sigma) in small-scale batch protocol
according to the manufacturer's suggestions. Purified
protein was eluted from the resin twice with 20 μl of the
elution buffer. Two microliters of the protein sample
(equivalent to 0.75 ml of the induced culture) was used
in 2-h-long cleavage of 0.5 μg of lambda DNA. If the
banding pattern generated by a variant was distinct
from that generated by the wild-type enzyme, the
variant was further characterized by a cleavage assay
on a panel of 10 substrates (444-bp DNA fragments
derived from pKSII Bluescript vector (Stratagene))
containing all combinations of the central dinucleotide
in the NlaIV recognition site. For kinetic measure-
ments, selected variants were purified from 2 l of
induced cultures as described before [6].
Cleavage assay
All cleavage assays were performed at 37 °C in
Fermentas Tango buffer [33 mM Tris-acetate
(pH 7.9), 10 mM magnesium acetate, 66 mM potas-
sium acetate and 0.1 mg/ml BSA]. Real-time kinetics
of DNA cleavage were followed for 5 min in
Shimidzu spectrofluorometer [38] using a hairpin
substrate with a single NlaIV site close to the base of
the stalk (Supplementary Fig. S3). The oligonucle-
otide substrate contained a ROX label at the 5′ end
and a BHQ2 quencher at the 3′ end; therefore, ROX
fluorescence in the annealed molecule wasquenched. Upon cleavage, the 7-bp fragment
containing the labeled ends of the substrate dena-
tured at the reaction temperature (37 °C, calculated
Tm = 6 °C) resulting in the separation of the
fluorophore and quencher and a fluorescence
increase. To convert fluorescence units into the
molar concentration of the product, the increase of
fluorescence for 200 nM substrate upon overnight
cleavage with wt enzyme was recorded. Initial
cleavage rates at varying substrate concentrations
(5–200 nM) were measured and used to calculate
Michaelis–Menten kinetic constants. Measurements
were made in triplicate.
Protein expression and purification for crystal-
lization
The NlaIV variant with the N-terminal MGSSHHHHH
HSSGLVPRGSH was used for crystallographic pur-
poses. The protein was expressed from pNlaNHis
plasmid that was constructed by cloning of the NdeI–
XhoI fragment of the amplification product of the NlaIV
ORF from pNlaRET plasmid with NlaNHisF and
NlaNHisR primers into the pET28a vector digested
with the same enzymes. The protein was expressed as
described above and purified on a Ni-NTA column
equilibrated with the buffer containing 15% glycerol,
50 mMHepes (pH 7.5), 200 mMNaCl, 10 mM imidaz-
ole, 10 mM β-mercaptoethanol and 0.1% Triton X-100.
The column was washed twice: with the above buffer
but with the amount of salt raised to 2 MNaCl, and then
with the above buffer containing 20 mM imidazole and
lacking Triton X-100. The elution was carried out with
the buffer containing 15% glycerol, 50 mM Hepes
(pH 7.5), 300 mM NaCl, 250 mM imidazole and
10 mM β-mercaptoethanol. Pooled peak fractions
were dialyzed against buffer containing 15% glycerol,
50 mMHepes (pH 7.5), 10 mMβ-mercaptoethanol and
50 mM KCl, and the histidine tag was removed with
thrombin according to the standard protocol leaving the
MIK sequence at the N-terminus. The obtained protein
was further purified onanSPcolumn in the 50 mM–1 M
KCl gradient in the same buffer. The buffer of the
purified protein preparation was exchanged on PD-10
column to 15% glycerol, 50 mM Hepes (pH 7.5),
50 mM KCl, 10 mM DTT and 5 mM CaCl2.
Crystallization and structure determination
The NlaIV crystals were grown by sitting drop vapor
diffusion method. The protein solution contained
10 mg/ml of the enzyme in 15% glycerol, 50 mM
Hepes (pH 7.5), 50 mM KCl and 10 mM DTT and
5 mMCaCl2. It wasmixedwith adouble-strandedDNA
oligonucleotide in 1:1 ratio (NlaIV dimer and dsDNA).
The oligowas composed of the 5′-ATGGTACCTGC-3′
and 5′-CAGGTACCATG-3′ strands, which upon an-
nealing produced single-nucleotide 3′ overhangs.
Crystallization was performed by mixing of the
Table 3. Data collection and refinement statistics
Data collection statistics
Space group P6(2)22
Cell dimensions
a (Å) 110.4
c (Å) 209.0
Wavelength (Å) 1.05
Resolution range (Å) 30–2.8
Lowest shell 30–8.1
Highest shell 2.97–2.8
Total reflections 142,779
Unique reflections 18,997
Completeness (%)a 98.5 (88.0, 98.6)
Multiplicitya 7.5 (6.5, 7.7)
Mean I/σIa 28.9 (74.3, 1.7)
CC1/2 (%)
a 100 (100, 77.5)
Rmerge (%)
a 4.0 (1.9, 98.6)
Rmeas (%)
a 4.3 (2.1, 105.2)
Solvent content (%) 58
Biso from Wilson (Å
2) 98.5
Refinement statistics
Protein atoms excluding H 2086
Solvent molecules 125
Rcryst (%) 19.10
Rfree (%) 22.10
RMSD bond lengths (Å) 0.007
RMSD angles (°) 1.083
Ramachandran favored region (%) 97.5
Ramachandran allowed region (%) 100
Molprobity clashscore 0
a Statistics for the highest- and lowest-resolution shell are indicated
in brackets.
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solution containing 2 M NaCl and 100 mM citric acid
(pH 5). The crystals grew in the P6(2)22 space group.
For cryo-protection, the crystals were soaked in the
buffer containing 4 μl of 80% glycerol and 6 μl of the
crystallization buffer. The native data set of 2.8 Å
resolution was collected at 1.05 Å wavelength at the
BW6 beamline of the DESY synchrotron (Hamburg,
Germany). Since the structure solution with the help of
molecular replacement proved difficult, the crystals
were soaked with Ta6Br12
2+ solution [39]. A tiny amount
of solid Ta6Br12
2+ was dissolved in the reservoir buffer.
The soaking was performed for 1 min at room
temperature. A two-wavelength MAD data set was
collected at the MX 14.2 beamline of BESSY
synchrotron (Berlin, Germany) at the 1.25489 Å
(peak) and 1.25531 Å (inflection point) wavelengths
(data to 3.0 and 3.2 Å resolution, respectively). The
anomalous signal of the data collected at 1.25489 Å
dropped below CCano of 25% at approximately 4.5 Å
resolution. The data were processed with autoPROC
[40] and STARANISO/XDS [41,42] programs. The
structure was solved with the autoSHARP program
[43]. Two-wavelength MAD was used to locate one
strong heavy atom site with the help of the SHELXD
program [44] [CC(all/weak) 42.10/29.30, PATFOM
21.63, CFOM 71.40]. The initial heavy atom param-
eters were submitted to heavy atom refinement and
phasing in SHARP [45] [leading to overall FOM
(acentric/centric) of 0.35/0.29], followed by density
modification with SOLOMON [46]. A spherical aver-
aged version of the Ta6Br12
2+ cluster was used to
describe the heavy atom binding sites via special form
factors as implemented in SHARP [45]. The resulting
phases were further improved with the help of DM [47]
and submitted to iterative density modification with
PARROT [47] and model building with BUCCANEER
[48] programs. The preliminarymodel was refinedwith
BUSTER [49] and subsequently rebuilt with the ARP/
wARP program [50]. The best parts of both models
were manually combined and once again automati-
cally rebuilt with ARP/wARP and BUCCANEER. The
resulting structurewas refined with theCOOT [51] and
REFMAC [52] programs, using isotropically truncated
diffraction data. Data collection and refinement statis-
tics are shown in Table 3. The final model coordinates
and the corresponding structure factors were submit-
ted to PDB with the 6QM2 accession code.
Molecular modeling
A preliminary model of NlaIV–DNA complex in a
closed conformation (protein wrapped around the
DNA, with active sites positioned for a double-
stranded DNA cleavage) has been obtained com-
putationally. Briefly, we generated a crude approx-
imation of the EcoRV-like binding mode by
superimposing NlaIV protomers onto the EcoRV–
DNA dimer structure (PDB: 1EO3) [53]. The catalyticcores of individual NlaIV protomers and the dimer-
ization region involving fragments of both protomers
were moved as independent rigid bodies to max-
imize the fit of active sites, preserve the dimerization
mode and maintain the continuity of the polypeptide
chains. Subsequently, the crystallographically de-
termined structure of NlaIV in an open conformation
without the DNA was subjected to the computational
normal mode analysis using the NOMAD server [54].
The procedure was applied to identify potential
conformational changes involving all atoms of
NlaIV dimer that could bring the molecule from the
experimentally observed unbound conformation to
the predicted bound conformation. The final model of
NlaIV complex was constructed by splicing the
catalytic domains and the dimerization region of
NlaIV. DNA coordinates were copied from the
EcoRV–DNA complex followed by computational
mutagenesis to represent the NlaIV target se-
quence. The NlaIV model in the closed conformation
was briefly optimized to improve local geometry and
to reduce steric clashes. Extensive simulations of
interactions were not attempted, as the model is not
supposed to be accurate at the atomic level and is
currently only used to illustrate the key assumptions
about the mutual disposition of key structural
elements and functionally important residues.
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ing structure factors were submitted to Protein Data
Bank with the accession number PDB ID: 6QM2.Acknowledgments
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